CIBC Bancorp USA’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
CIBC Bancorp USA's TECH Position: Q3 2026 in Review
CIBC Bancorp USA increased its Bio-Techne (TECH) stake by 739% in Q3 2026, buying an estimated $34.3M and bringing the position to 540,258 shares worth $39.2M. The position accounts for 0.05% of the portfolio, ranked #294.
CIBC Bancorp USA first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. 583 funds tracked by Wall St. Rank hold TECH as of Q3 2026.
- CIBC Bancorp USA held 540,258 shares of Bio-Techne worth $39.2M as of Q3 2026.
- CIBC Bancorp USA bought 475,857 Bio-Techne shares in Q3 2026, an estimated $34.3M.
- Bio-Techne made up 0.05% of CIBC Bancorp USA's portfolio in Q3 2026, its #294 holding.
- CIBC Bancorp USA first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
- 583 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.